Span Divergent Limited_Integrated Annual Report for the Financial Year 2024-2025 along with Notice of 45th Annual General Meeting
Awaiting price reaction for this filing.
Span Divergent Limited (formerly Span Diagnostics Ltd) has filed its Integrated Annual Report for FY 2024-25 along with the Notice of its 45th Annual General Meeting with BSE (Scrip Code: 524727). The AGM is scheduled for Monday, September 29, 2025 at 11:30 AM via video conferencing. Remote e-voting runs from September 26-28, 2025 with a cut-off date of September 22, 2025. Key business to be transacted includes: adoption of audited financial statements, re-appointment of Dr. Shefali Desai (director retiring by rotation), re-appointment of Y.B. Desai & Associates as statutory auditors for a second 5-year term (until 50th AGM), appointment of Mitesh Rana & Co as secretarial auditor for 5 years (FY 2025-26 to 2029-30), and shareholder approval for related party transactions. The related party approvals include transactions up to Rs 75 crore with Dryfruit Factory LLP, Rs 25 crore with Aranya Agri Biotech LLP, Rs 5 crore each with Span Diagnostics LLP, Biospan Scientific LLP, and subsidiary Biospan Contamination Control Solutions. An additional approval is sought for transactions up to Rs 5 crore each with Managing Director Viral P Desai, Director Pradip K Desai, and COO Sujata Desai.
This is primarily a routine annual filing, but shareholders should note the significant related party transaction approvals being sought, especially the Rs 75 crore limit with Dryfruit Factory LLP where the company is a partner. The e-voting window (Sept 26-28) is the key opportunity for shareholders to review and vote on these resolutions.